HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible usefulness of tianeptine in treatment-resistant depression.

AbstractOBJECTIVE:
Tianeptine is an atypical antidepressant drug, augmenting serotonin reuptake and preventing stress-associated changes in the brain. In this paper, we present the use of tianeptine in eight American treatment-resistant patients with major depressive disorder.
METHODS:
Two male and six female patients with major depressive disorder, aged 44-72 years with duration of the illness 3-40 years, were studied. All met criteria for treatment-resistant depression (TRD) as they failed four or more trials of medication, and two failed both ECT and Vagal Nerve Stimulation trials. In three patients, the drug was used as monotherapy, and in five, it was added to ongoing antidepressant treatment.
RESULTS:
The remission (≤ 7 points on the 17-item Hamilton Depression Rating Scale) after 8 weeks of treatment was obtained in four female patients (50%). Of them, three still require other psychotropic medications to remain in remission and all four responders have been in remission with ongoing treatment with tianeptine for > 2 years. In two patients, the drug was terminated due to the incidence of delirium, and in one, it was due to severe agitation.
CONCLUSION:
The results may suggest a possible usefulness of tianeptine in selected patients with TRD. They also point to a possible serious side effect of this drug not hitherto reported.
AuthorsEdward H Tobe, Janusz K Rybakowski
JournalInternational journal of psychiatry in clinical practice (Int J Psychiatry Clin Pract) Vol. 17 Issue 4 Pg. 313-6 (Oct 2013) ISSN: 1471-1788 [Electronic] England
PMID23668804 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antidepressive Agents, Tricyclic
  • Thiazepines
  • tianeptine
Topics
  • Adult
  • Aged
  • Akathisia, Drug-Induced
  • Antidepressive Agents, Tricyclic (adverse effects, pharmacology, therapeutic use)
  • Delirium (chemically induced)
  • Depressive Disorder, Treatment-Resistant (drug therapy)
  • Drug Approval
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Remission Induction (methods)
  • Thiazepines (adverse effects, pharmacology, therapeutic use)
  • Treatment Outcome
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: